Organisation paid for research Program year 2024 Source: CMS Open Payments

ACRC Trials - Austin - Hunt - PPDS

Neither a doctor nor a teaching hospital

Research payments

$2,426,141

83 payments

Through program year 2024, ACRC Trials - Austin - Hunt - PPDS is reported as receiving $2,426,141 in research payments, across 83 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2024	Research	$682,366	28
2023	Research	$1,743,775	55

Breakdown

Who paid Research payments · program years 2023–2024

Moderna TX, Inc. $2,426,141 83 payments

Studies the money was for Research payments · program years 2023–2024

A Phase 2/3, Randomized, Observer-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus (RSV), in Adults 60 Years of Age $1,793,547 35 payments
A Phase 2a, randomized, stratified, observer-blind study to evaluate the immunogenicity and safety of mRNA-1283 vaccine boosters for SARS-CoV-2 $226,707 7 payments
A Phase 3, Randomized, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age $187,246 29 payments
A Phase 2/3, Randomized, Observer-Blind, Placebo-Controlled Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 SARS-CoV-2 Vaccine in Healthy Adolescents 12 to <18 years of age $138,931 6 payments
A Phase 1, Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 18- to 30-year-old Healthy Adults $79,711 6 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.